Skip to main content

Vaccine Update Newsletter Archive

Vaccine Update Newsletter Archive

News

In the Journals: Nirsevimab

Find out about the results of a prospective, placebo-controlled trial in 8,058 healthy infants that served as the basis for licensure of nirsevimab.

News

In the Journals: Adenovirus and VITT

Vaccine-induced thrombotic thrombocytopenia (VITT) has been shown to follow vaccination with COVID-19 adenovirus vector vaccines. Now, two research studies have shown that VITT also follows adenovirus infection. Find out more.

Jump back to top